Transcat, Inc. (NASDAQ:TRNS - Get Free Report) CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the transaction, the chief executive officer now owns 103,688 shares in the company, valued at $11,553,953.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Transcat Stock Performance
TRNS stock traded down $1.60 on Tuesday, hitting $108.99. The company's stock had a trading volume of 31,954 shares, compared to its average volume of 37,939. The stock has a market cap of $962.38 million, a price-to-earnings ratio of 83.84 and a beta of 0.59. The firm has a 50 day moving average of $108.13 and a two-hundred day moving average of $101.28. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. Transcat, Inc. has a 1 year low of $74.89 and a 1 year high of $115.41.
Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Transcat had a net margin of 4.16% and a return on equity of 9.32%. The company had revenue of $65.17 million for the quarter, compared to analyst estimates of $63.36 million. Equities analysts predict that Transcat, Inc. will post 1.36 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Monashee Investment Management LLC purchased a new position in Transcat during the 3rd quarter worth $588,000. Quadrature Capital Ltd purchased a new stake in Transcat in the 3rd quarter valued at approximately $2,847,000. Rice Hall James & Associates LLC increased its position in Transcat by 59.2% during the 3rd quarter. Rice Hall James & Associates LLC now owns 28,781 shares of the scientific and technical instruments company's stock worth $2,820,000 after purchasing an additional 10,697 shares during the period. EAM Investors LLC purchased a new position in shares of Transcat during the 3rd quarter worth approximately $2,962,000. Finally, Comerica Bank purchased a new stake in shares of Transcat in the third quarter valued at approximately $5,221,000. 98.34% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
TRNS has been the topic of a number of recent analyst reports. TheStreet raised shares of Transcat from a "c+" rating to a "b" rating in a research report on Wednesday, January 31st. HC Wainwright raised their price objective on Transcat from $108.00 to $124.00 and gave the stock a "buy" rating in a report on Wednesday, January 31st.
Read Our Latest Report on Transcat
About Transcat
(
Get Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
